Peter Higgs

4.4k total citations
198 papers, 3.0k citations indexed

About

Peter Higgs is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, Peter Higgs has authored 198 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 151 papers in Epidemiology, 57 papers in Infectious Diseases and 56 papers in Hepatology. Recurrent topics in Peter Higgs's work include HIV, Drug Use, Sexual Risk (123 papers), Hepatitis C virus research (56 papers) and HIV/AIDS Research and Interventions (51 papers). Peter Higgs is often cited by papers focused on HIV, Drug Use, Sexual Risk (123 papers), Hepatitis C virus research (56 papers) and HIV/AIDS Research and Interventions (51 papers). Peter Higgs collaborates with scholars based in Australia, Iran and United Kingdom. Peter Higgs's co-authors include Campbell Aitken, Margaret Hellard, Paul Dietze, Bahram Armoon, David Moore, Michael Kerger, Mark Stoové, Rachel Sacks‐Davis, Danielle Horyniak and Barry J. Fox and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Hepatology.

In The Last Decade

Peter Higgs

189 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Higgs Australia 30 2.0k 848 771 653 531 198 3.0k
Jennifer Lorvick United States 28 2.0k 1.0× 405 0.5× 978 1.3× 796 1.2× 614 1.2× 83 2.6k
Noya Galai United States 45 4.3k 2.1× 1.8k 2.1× 3.0k 3.8× 1.1k 1.7× 873 1.6× 182 7.4k
Peter R. Kerndt United States 40 2.6k 1.3× 292 0.3× 2.1k 2.7× 549 0.8× 1.2k 2.3× 140 4.9k
Clyde B. McCoy United States 36 2.8k 1.4× 160 0.2× 1.5k 1.9× 763 1.2× 1.6k 3.0× 130 4.5k
Pedro Mateu‐Gelabert United States 30 1.6k 0.8× 354 0.4× 644 0.8× 889 1.4× 585 1.1× 106 2.5k
Jennifer L. Evans United States 34 2.6k 1.3× 1.1k 1.3× 1.1k 1.4× 677 1.0× 902 1.7× 106 3.8k
Héctor M. Colón Puerto Rico 25 1.4k 0.7× 212 0.3× 870 1.1× 343 0.5× 586 1.1× 94 1.9k
Lucy Platt United Kingdom 34 3.2k 1.6× 983 1.2× 1.7k 2.2× 648 1.0× 462 0.9× 89 3.9k
Hasina Samji Canada 26 1.2k 0.6× 447 0.5× 955 1.2× 265 0.4× 418 0.8× 87 2.6k
Diana Hartel United States 22 2.2k 1.1× 129 0.2× 2.0k 2.6× 557 0.9× 381 0.7× 40 3.5k

Countries citing papers authored by Peter Higgs

Since Specialization
Citations

This map shows the geographic impact of Peter Higgs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Higgs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Higgs more than expected).

Fields of papers citing papers by Peter Higgs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Higgs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Higgs. The network helps show where Peter Higgs may publish in the future.

Co-authorship network of co-authors of Peter Higgs

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Higgs. A scholar is included among the top collaborators of Peter Higgs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Higgs. Peter Higgs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
O’Keefe, Daniel, Bridget Draper, Kathleen E. Ryan, et al.. (2023). The eliminate hepatitis C (EC) experience study: baseline characteristics of a cohort of people who inject drugs in Melbourne, Australia. BMJ Open. 13(7). e071665–e071665. 2 indexed citations
3.
O’Keefe, Daniel, et al.. (2023). Epidemiology of acute infections in people who inject drugs in Australia. Drug and Alcohol Review. 43(1). 304–314. 3 indexed citations
4.
Higgs, Peter, et al.. (2023). Experiences of participation in a longitudinal cohort study of people who inject drugs in Victoria, Australia. Drugs Education Prevention and Policy. 31(2). 229–238.
6.
Douglass, Caitlin, et al.. (2022). Social Media and Online Digital Technology Use Among Muslim Young People and Parents: Qualitative Focus Group Study. JMIR Pediatrics and Parenting. 5(2). e36858–e36858. 6 indexed citations
7.
Higgs, Peter, et al.. (2022). Health service utilisation and access for people who inject drugs during COVID‐19. Drug and Alcohol Review. 41(6). 1304–1310. 16 indexed citations
8.
Wells, Yvonne, et al.. (2022). A Retrospective Cohort Study of Women and Men Living with HIV, Attending an HIV Clinic in Australia. Women s Health Reports. 3(1). 915–923. 1 indexed citations
9.
Lafferty, Lise, Sophia Schroeder, Alison D. Marshall, et al.. (2022). Trust and service engagement among people who inject drugs after release from prison. International Journal of Drug Policy. 111. 103925–103925. 3 indexed citations
10.
Carter, Gregory, Matthew J. Spittal, Dimitri Gerostamoulos, et al.. (2022). Diagnostic accuracy for self‐reported methamphetamine use versus oral fluid test as the reference standard in a methamphetamine‐dependent intervention trial population. Addiction. 118(3). 470–479. 6 indexed citations
11.
Dietze, Paul, et al.. (2021). Barriers to women's disclosure of and treatment for substance use during pregnancy: A qualitative study. Women and Birth. 35(6). 576–581. 17 indexed citations
12.
Sharhani, Asaad, Zahra Jorjoran Shushtari, Azam Rahmani, et al.. (2021). Incidence of HIV and HCV in people who inject drugs: a systematic and meta-analysis review protocol. BMJ Open. 11(1). e041482–e041482. 5 indexed citations
13.
Richmond, Jacqueline A., Jeanne Ellard, Jack Wallace, et al.. (2018). Achieving a hepatitis C cure: a qualitative exploration of the experiences and meanings of achieving a hepatitis C cure using the direct acting antivirals in Australia. SHILAP Revista de lepidopterología. 3(1). 8–8. 42 indexed citations
14.
Wright, Cassandra, et al.. (2018). “I'm obviously not dying so it's not something I need to sort out today”: Considering hepatitis C treatment in the era of direct acting antivirals. Infection Disease & Health. 24(2). 58–66. 20 indexed citations
15.
Horyniak, Danielle, Peter Higgs, Shelley Cogger, & Paul Dietze. (2017). The role of respect in interactions with police among substance-using African refugee young people in Melbourne, Australia. Journal of Ethnicity in Criminal Justice. 15(2). 185–204. 8 indexed citations
16.
Peach, Elizabeth, Shelley Cogger, Miles Morris, et al.. (2015). Hazardous alcohol use and concomitant blood-borne virus infection in a local urban population of people who inject drugs: Implications for approaches to harm reduction. Drug and Alcohol Review. 34. 50–51. 1 indexed citations
17.
Sacks‐Davis, Rachel, Galina Daraganova, Campbell Aitken, et al.. (2011). 1178 MOLECULAR EPIDEMIOLOGY OF HEPATITIS C IN A SOCIAL NETWORK OF YOUNG PEOPLE WHO INJECT DRUGS. Journal of Hepatology. 54. S465–S466. 1 indexed citations
18.
Higgs, Peter, Kei Owada, Margaret Hellard, Robert Power, & Lisa Maher. (2008). Gender, culture and harm: an exploratory study of female heroin users of Vietnamese ethnicity. Culture Health & Sexuality. 10(7). 681–695. 20 indexed citations
19.
Higgs, Peter, David Moore, & Campbell Aitken. (2006). Engagement, reciprocity and advocacy: ethical harm reduction practice in research with injecting drug users. Drug and Alcohol Review. 25(5). 419–423. 21 indexed citations
20.
Aitken, Campbell, et al.. (2002). The impact of a police crackdown on a street drug scene: evidence from the street. International Journal of Drug Policy. 13(3). 193–202. 228 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026